Advertisement

Topics

Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum

2014-08-27 03:14:05 | BioPortfolio

Summary

Bioequivalence between oral nicotine replacement products and Nicorette® gum.

Description

This study compares a new oral Nicotine Replacement Therapy (NRT) product containing 2 and 4 mg nicotine with Nicorette® gum 2 mg and 4 mg, after 12 hours of nicotine abstinence, with respect to nicotine pharmacokinetics, during 10 hours after start of administration. Single doses of each treatment are given once in the morning during four separate treatment visits scheduled in a crossover setting with randomized treatment sequences. The study will include 88 healthy smokers between 18-50 years, who have been smoking at least 10 cigarettes daily during at least one year preceding inclusion. Subjects and study personnel will be aware of which treatment is administered at a given visit.

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Tobacco Dependence

Intervention

Nicotine, Nicorette® (Nicotine Gum)

Location

Berzelius Clinical Research Center
Linköping
Sweden
SE-582 25

Status

Completed

Source

Johnson & Johnson Consumer & Personal Products Worldwide

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:14:05-0400

Clinical Trials [1130 Associated Clinical Trials listed on BioPortfolio]

Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product

A comparison of three products for oral nicotine replacement with respect to pharmacokinetics after single-dose of nicotine.

Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers.

This is a research study to verify the same effectiveness and safety profile for the test products, nicotine 2 mg gum and nicotine 4 mg gum, as for the already approved products, Nicorette...

Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum

This study examines the bioequivalence between an oral nicotine replacement product and Nicorette® gum.

Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum

Single-dose pharmacokinetics with two new oral nicotine replacement products and Nicorette® gum.

Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum

Single-dose pharmacokinetics with a new oral nicotine replacement product and Nicorette® gum.

PubMed Articles [2293 Associated PubMed Articles listed on BioPortfolio]

Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation.

Nicotine addiction is the proximate cause of disease and death from cigarette smoking. In 1994, we proposed reducing the nicotine content of cigarettes to non-addicting levels to reduce the risk of yo...

Pregnancy-Induced Increases in the Nicotine Metabolite Ratio: Examining Changes During Antepartum and Postpartum.

Pregnancy-induced increases in nicotine metabolism may contribute to difficulties in quitting smoking during pregnancy. However, the time-course of changes in nicotine metabolism during early and late...

Rewarding effects of nicotine in adolescent and adult male and female rats as measured using intracranial self-stimulation.

Tobacco is highly addictive and after the development of dependence it is difficult to quit smoking. Therefore, it is important to understand the factors that play a role in the initiation of smoking....

The United States is not the World: Response to Zeller et al's Call for Discussion on Nicotine Regulation.

The Nicotine Continuum and Regulation: Additional Challenges to Converting an Important Concept into Policy: Commentary on Zeller.

Medical and Biotech [MESH] Definitions

Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.

SMOKING of non-TOBACCO (or NICOTINE-containing) substances.

A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.

Chewing gum which contains NICOTINE.

SMOKING vapors produced from ELECTRONIC NICOTINE DELIVERY SYSTEMS.

More From BioPortfolio on "Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Searches Linking to this Trial